Plant ID: NPO16913
Plant Latin Name: Helianthus maximiliani
Taxonomy Genus: Helianthus
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
73297
Plant-of-the-World-Online:
n.a.
China
BCL2; | |
P4HB; AKR1B1; UBE2N; | |
BACE1; |
Cytochrome P450 Enzymes: | CYP19A1; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Aspartic protease | BACE1 | Beta-secretase 1 | P56817 | CHEMBL4822 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Enzyme_unclassified | P4HB | Protein disulfide-isomerase | P07237 | CHEMBL5422 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | UBE2N | Ubiquitin-conjugating enzyme E2 N | P61088 | CHEMBL6089 |
Miscellaneous ion channel | BCL2 | Apoptosis regulator Bcl-2 | P10415 | CHEMBL4860 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0023052; signaling | GO:0023051; regulation of signaling | 3.086E-05 | 2.529E-01 | AKR1B1, BACE1, BCL2, CYP19A1, P4HB, UBE2N |
BP | GO:0032501; multicellular organismal process | GO:0035265; organ growth | 3.484E-05 | 2.529E-01 | BCL2, CYP19A1 |
BP | GO:0050896; response to stimulus | GO:0006979; response to oxidative stress | 1.067E-04 | 3.442E-01 | AKR1B1, BCL2, P4HB |
BP | GO:0008152; metabolic process | GO:0042446; hormone biosynthetic process | 1.460E-04 | 3.442E-01 | AKR1B1, CYP19A1 |
BP | GO:0008152; metabolic process | GO:0006694; steroid biosynthetic process | 6.225E-04 | 3.442E-01 | AKR1B1, CYP19A1 |
BP | GO:0009987; cellular process | GO:0071453; cellular response to oxygen levels | 6.323E-04 | 3.442E-01 | BCL2, P4HB |
MF | GO:0003824; catalytic activity | GO:0009055; electron transfer activity | 4.578E-04 | 3.442E-01 | AKR1B1, CYP19A1 |
MF | GO:0003824; catalytic activity | GO:0016705; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 9.396E-04 | 3.988E-01 | CYP19A1, P4HB |
MF | GO:0005488; binding | GO:0051434; BH3 domain binding | 1.552E-03 | 4.761E-01 | BCL2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09120 Genetic Information Processing | 09123 Folding, sorting and degradation | hsa04141 | Protein processing in endoplasmic reticulum | 1.041E-03 | 3.228E-02 | BCL2, P4HB |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.491E-02 | 6.108E-02 | CYP19A1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 8.967E-03 | 6.108E-02 | AKR1B1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 1.520E-02 | 6.108E-02 | BCL2 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 3.285E-02 | 6.108E-02 | BCL2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04064 | NF-kappa B signaling pathway | 2.758E-02 | 6.108E-02 | BCL2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 3.051E-02 | 6.108E-02 | BCL2 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 3.489E-02 | 6.108E-02 | BCL2 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 3.547E-02 | 6.108E-02 | BCL2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 3.547E-02 | 6.108E-02 | BCL2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Cancer | C00-C96 | BCL2; |
C00-D49: Neoplasms | Multiple myeloma | C90 | BCL2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | BCL2; |
C00-D49: Neoplasms | Breast cancer | C50 | BCL2; |
C00-D49: Neoplasms | Chronic lymphocytic leukaemia | C91 | BCL2; |
C00-D49: Neoplasms | Prostate cancer | C61 | BCL2; |
C00-D49: Neoplasms | Leukemia | C90-C95 | BCL2; |
G00-G99: Diseases of the nervous system G00-G99 | Amyotrophic lateral sclerosis | G12.2 | BCL2; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | BCL2; |
C00-D49: Neoplasms | Advanced melanoma | C43 | BCL2; |